These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning. Piscitelli O; Digilio MC; Capolino R; Longo D; Di Ciommo V Dev Med Child Neurol; 2012 Jan; 54(1):49-51. PubMed ID: 22107256 [No Abstract] [Full Text] [Related]
24. Glioneuronal tumours in neurofibromatosis type 1: MRI-pathological study. Fedi M; Anne Mitchell L; Kalnins RM; Gutmann DH; Perry A; Newton M; Brodtmann A; Berkovic SF J Clin Neurosci; 2004 Sep; 11(7):745-7. PubMed ID: 15337138 [TBL] [Abstract][Full Text] [Related]
26. [Neurofibromatosis in children. Our experience]. López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048 [TBL] [Abstract][Full Text] [Related]
27. [Cognitive dysfunction and emotional disturbances in children with neurofibromatosis type one (Recklinghausen's disease). Review of the literature]. Trzcińska M; Borkowska A Psychiatr Pol; 2005; 39(2):371-81. PubMed ID: 15881631 [TBL] [Abstract][Full Text] [Related]
28. Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic. North K J Child Neurol; 1993 Oct; 8(4):395-402. PubMed ID: 8228039 [TBL] [Abstract][Full Text] [Related]
29. Brain tumors in children with neurofibromatosis: computed tomography and magnetic resonance imaging. Gray J; Swaiman KF Pediatr Neurol; 1987; 3(6):335-41. PubMed ID: 3149475 [TBL] [Abstract][Full Text] [Related]
30. [Characteristics of neurofibromatosis type 1 in Martinique: a preliminary report]. Derancourt C; Briand N; Deschamps R; Janoyer M; Quist D; René Corail P; Bellance R; Sarrazin E Ann Dermatol Venereol; 2015 Jan; 142(1):50-1. PubMed ID: 25600796 [No Abstract] [Full Text] [Related]
31. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. North K; Joy P; Yuille D; Cocks N; Mobbs E; Hutchins P; McHugh K; de Silva M Neurology; 1994 May; 44(5):878-83. PubMed ID: 8190291 [TBL] [Abstract][Full Text] [Related]
32. [Selected problems of neurofibromatosis with presentation of a case of multiple intracranial and intramedullary tumors]. Stachura Z; Zralek C; Siemianowicz S; Kiczka-Zralek M; Zawadzki T; Kluczewska E; Giec-Lorenc A Neurol Neurochir Pol; 1998; 32(6):1563-9. PubMed ID: 10358844 [TBL] [Abstract][Full Text] [Related]
33. Neurofibromatosis type 1. Legius E; Descheemaeker MJ; Fryns JP; Van den Berghe H Genet Couns; 1994; 5(3):225-41. PubMed ID: 7811422 [TBL] [Abstract][Full Text] [Related]
34. Fatal glioblastoma multiforme in a patient with neurofibromatosis type I: the dilemma of systematic medical follow-up. Distelmaier F; Fahsold R; Reifenberger G; Messing-Juenger M; Schaper J; Schneider DT; Göbel U; Mayatepek E; Rosenbaum T Childs Nerv Syst; 2007 Mar; 23(3):343-7. PubMed ID: 17009007 [TBL] [Abstract][Full Text] [Related]
35. [Developmental manifestation in children with neurofibromatosis type 1]. Cohen R; Shuper A Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842 [TBL] [Abstract][Full Text] [Related]